The number of lawsuits in multidistrict litigation (MDL) against makers of testosterone replacement therapies alleging the treatments caused cardiovascular side effects including death have significantly increased in recent months, according to a Reuters analysis of statistics from the U.S. Judicial Panel on Multidistrict Litigation. More than 4,000 lawsuits have been filed in federal court against various manufacturers of products including Androgel, Testim and Axiron. Testosterone treatments are approved to treat hypogonadism, a rare condition in which men do not produce enough testosterone due to injury or disease. The level of testosterone declines as men age – a natural process of aging. Testosterone ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.